137 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 48-week results of an open-label extension study
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: J. Goralski, C. Daines, J. Pittman, J. Rayment, P. Robinson, R. Thursfield, F. Stehling, F. Ratjen, N. Ahluwalia, C. Chu, P. Menon, T. Weinstock, M. Mall, for the VX20-445-112 Study Group Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research